Gene Panel Market Growth Opportunities: Insights from 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Gene Panel Industry Compare Between 2025 And 2029?

The gene panel market has witnessed rapid expansion in recent years. Its valuation is anticipated to climb from $2.14 billion in 2024 to $2.47 billion in 2025, achieving a compound annual growth rate (CAGR) of 15.2%. This past growth can be ascribed to several factors, including the increasing occurrence of hereditary disorders, the escalating need for genetic screening, heightened research and development activities, the rising prevalence of congenital diseases, and a greater demand for advanced treatment options.

The gene panel market is anticipated to experience substantial growth in the upcoming years, with its size projected to reach $4.33 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 15.1%. This expansion during the forecast period is primarily driven by the rising prevalence of chronic diseases, an increase in cancer diagnoses, enhanced public knowledge of genetic testing, and greater government initiatives coupled with increased healthcare expenditure. Significant trends expected in this period involve the evolution of gene panel technology, strategic partnerships, the implementation of personalized treatment approaches, the incorporation of artificial intelligence, and the utilization of advanced bioinformatics tools.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21190&type=smp

Which Major Market Drivers Are Shaping The Future Of The Gene Panel Market?

The rising incidence of cancer is anticipated to fuel the expansion of the gene panel market moving forward. Cancer encompasses a range of diseases defined by the uncontrolled proliferation and spread of abnormal cells, which can infiltrate and harm surrounding tissues and organs. The increase in cancer cases stems from factors such as aging populations, evolving lifestyles, environmental exposures, and enhanced detection and diagnostic technologies. Gene panels aid in cancer management by allowing for comprehensive genetic testing to pinpoint mutations and alterations in specific genes, thereby guiding tailored treatment plans and improving patient outcomes. For instance, the World Health Organization, a Switzerland-based intergovernmental entity, indicated in February 2024 that an estimated 9.7 million people died from cancer in 2022, with 20 million new cases identified. Lung cancer constituted 12.4% of all new cases, amounting to 2.5 million new instances, making it the most prevalent cancer globally. Thus, the escalating prevalence of cancer is a significant driver for the growth of the gene panel market.

How Is The Gene Panel Market Classified Into Different Segments?

The gene panelmarket covered in this report is segmented –

1) By Product And Services: Test Kits; Testing Services

2) By Technology: Amplicon-Based; Hybridization-Based; Other Technologies

3) By Design: Predesigned Gene Panel; Customized Gene Panel

4) By Application: Cancer Risk Assessment; Diagnosis Of Congenital Diseases; Pharmacogenetics; Other Applications

5) By End-User: Research Institutes; Hospital; Diagnosis Centers; Pharmaceutical Companies; Other End-Users

Subsegments:

1) By Test Kits: Predesigned Gene Panels; Customized Gene Panels

2) By Testing Services: Cancer Risk Assessment Panels; Pharmacogenetic Testing Panels; Neurological Disorder Panels; Cardiovascular Disease Panels; Rare Disease Panels

Which Competitive Trends Are Defining The Gene Panel Market Structure?

Leading companies in the gene panel market are concentrating on developing innovative technologies, such as oncology panels, to enhance the accuracy, efficiency, and comprehensiveness of cancer diagnostics and personalized treatment strategies. Oncology panels are specialized gene analysis tools that scrutinize multiple genes linked to cancer, identifying genetic mutations and alterations to aid in the diagnosis, prognosis, and treatment of cancer. For instance, in May 2023, Vizgen Inc., a US-based biotechnology company, unveiled the MERFISH PanCancer Pathways Panel, offering a customizable choice for scientists entering the domain of spatial genomics. These predesigned panels are tailored for various research applications, including cancer studies, and are optimized for improved error robustness, delivering reliable and reproducible results. By integrating spatial information with gene expression data, these panels provide deeper insights into tumor microenvironments and cellular interactions, thereby facilitating more targeted and personalized cancer research and therapeutic development. This launch signifies a substantial advancement in spatial biology, allowing researchers to explore complex biological systems with a level of detail previously unattainable.

Who Are The Primary Competitors In The Global Gene Panel Market?

Major companies operating in the gene panel market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Intermountain Healthcare, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., OPKO Health Inc., Myriad Genetics Inc., Guardant Health Inc., Invitae Corp., Integrated DNA Technologies Inc., Bio-Rad Laboratories Inc., Novogene Corporation, Fulgent Genetics Inc., MedGenome Inc., OriGene Technologies Inc., Centogene AG, Blueprint Genetics Inc., BIONEER Corporation, BGI Group Ltd., Vizgen Inc., Primbio Research Institute LLC

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gene-panel-global-market-report

How Do Regional Market Performances Compare Within The Gene Panel Industry?

North America was the largest region in the gene panel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene panel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Gene Panel Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21190&type=smp

Browse Through More Reports Similar to the Global Gene Panel Market 2025, By The Business Research Company

Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Prenatal And Newborn Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Direct To Consumer Dtc Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795